Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP
Abstract
Yeast two-hybrid system was employed to isolate novel proteins that physically interact with PU.1, a member of Ets family transcription factors. Sequence analyses of several isolated clones positive for beta-galactosidase activity revealed that one of these clones was confirmed to encode a transcriptional coactivator, CREB binding protein (CBP). GST binding assay showed that the interacting sites were located at the transcriptional activation domain of PU.1 through 74-122 and the region spanning residues 1283-1915 of CBP. CBP potentiated PU.1-mediated transcription of the reporter gene driven by the multimerized PU.1-binding sites, suggesting that CBP functions as a coactivator for PU.1. Considering that CBP is a limited cellular component to function as a coactivator for several transcription factors, CBP may mediate synergistic and antagonistic interactions between PU.1 and other transcription factors during the process of hematopoietic cell differentiation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PU.1 can interact with CBP/p300 and TRIM33.
“as PU.1 can interact with CBP/p300 (refs 39, 40) and TRIM33”
From TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation (2015) · cites this paper as [39]
There is limited understanding of the mechanisms that determine coactivator versus corepressor recruitment by RUNX1 and PU.1.
“There is limited understanding of the mechanisms that determine coactivator versus corepressor recruitment by RUNX1 and PU.1.17–20”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [18]
PU.1 can interact with coactivators or corepressors to function as either a transcriptional activator or a transcriptional repressor.
“PU.1 can interact with coactivators or corepressors to function as either a transcriptional activator or a transcriptional repressor.17–19”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [18]
The mechanisms that regulate corepressor versus coactivator interactions of RUNX1 and PU.1 are incompletely understood.
“However, the mechanisms that regulate corepressor versus coactivator interactions of RUNX1 and PU.1 are incompletely understood.17–20”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [18]
CBP stimulates PU.1 activity in transient transfections.
“and CBP stimulates PU.1 activity in transient trans- fections (82).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [82]
PU.1 is bifunctional: CBP binding activates PU.1 transcription, while TLE-4 supports PU.1-dependent repression.
“PU.1 is a bifunctional protein as for instance CBP binding leads to PU.1 transcriptional activation [47], whereas TLE-4 was found to support PU.1-dependent repres-sion [46].”
From PKCδ-Induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells (2011) · cites this paper as [47]
GST binding assays revealed that a portion of the transcriptional activation domain of PU.1 (amino acids 74-122) directly interacts with the region spanning residues 1283-1915 of CBP.
“GST binding assays revealed that a portion of the transcriptional activation domain of PU.1 (amino acids 74–122) directly interacts with the region spanning residues 1283–1915 of CBP (Fig. 4).”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [78]
CBP enhances PU.1-mediated transcription of multimerized PU-box luciferase reporter constructs, suggesting CBP acts as a co-activator for PU.1.
“CBP enhances PU.1-mediated transcription of multimerized PU-box luciferase reporter constructs, suggesting that CBP acts as a co-activator for the transcription factor PU.1.”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [78]
Because the amount of CBP is limited in cells, CBP may mediate positive and negative cross-talk between PU.1 and other transcription factors during haematopoietic cell differentiation.
“Because the amount of CBP is limited in cells, CBP may mediate positive and negative cross-talk between PU.1 and other transcription factors in the process of haematopoietic cell differentiation [78].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [78]
In CV-1 cells, but not in NIH 3T3 cells, cooperation between Myb and C/EBP-α depended on the integrity of the PU.1-binding site.
“In CV-1 cells, but not in NIH 3T3 cells, cooperation between Myb and C/EBP-α depended on the integrity of the PU.1-binding site [78].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [78]
CBP/p300 is a co-activator of PU.1 that binds to the transactivation domain of PU.1.
“One such candidate is CBP/p300, a co-activator of PU.1 [78], which binds to the transactivation domain of PU.1.”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [78]
Activation of EICE-dependent transcription may in part be due to recruitment of coactivator/histone acetylase CBP/p300, since CBP/p300 can interact with PU.1 but not ICSBP.
“This activation may in part be due to the recruitment of coactivator/ histone acetylase CBP/p300, since CBP/p300 can interact with PU.1 (but not ICSBP) (32, 59).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [59]
This activation seems to involve other factors, notably the coactivator/histone acetylase CBP/p300, with which PU.1 is shown to interact.
“This activation seems to involve other factors, notably the coactivator/histone acetylase CBP/p300, with which PU.1 is shown to interact (59).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [59]
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952 · see citing works
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · see citing works
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150 · see citing works
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052 · see citing works
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · see citing works
Nuclear protein CBP is a coactivator for the transcription factor CREB
Kwok, R. P. S., Lundblad, J. R., Chrivia, J. C., Richards, J. P., Bächinger, H. P., Brennan, R. G., Roberts, S. G. E., Green, M. R., & Goodman, R. H. (1994) · Nature · doi:10.1038/370223a0 · Cited by 1,443 · see citing works
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · see citing works
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · see citing works
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 930 · see citing works
The Ets family of transcription factors
Wasylyk, B., Hahn, S. L., & Giovane, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 835 · see citing works
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 811 · see citing works
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · see citing works
Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
Arias, J., Alberts, A. S., Brindle, P. K., Claret, F. X., Smeal, T., Karin, M., Feramisco, J. R., & Montminy, M. (1994) · Nature · doi:10.1038/370226a0 · Cited by 726 · see citing works
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D., & Nabel, G. J. (1997) · Science · doi:10.1126/science.275.5299.523 · Cited by 722 · see citing works
Shivdasani, R. A., Rosenblatt, M., Zucker‐Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 687 · see citing works
Synergistic activation of transcription by CBP and p53
Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 596 · see citing works
Lundblad, J. R., Kwok, R. P. S., Laurance, M. E., Harter, M. L., & Goodman, R. H. (1995) · Nature · doi:10.1038/374085a0 · Cited by 585 · see citing works
The transcriptional control of hematopoiesis [see comments]
Shivdasani, R., & Orkin, S. (1996) · Blood · doi:10.1182/blood.v87.10.4025.bloodjournal87104025 · Cited by 560 · see citing works
A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
Arany, Z., Newsome, D., Oldread, E., Livingston, D. M., & Eckner, R. (1995) · Nature · doi:10.1038/374081a0 · Cited by 533 · see citing works
Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., & Livingston, D. M. (1996) · Nature · doi:10.1038/383344a0 · Cited by 493 · see citing works
Two contact regions between Stat1 and CBP/p300 in interferon γ signaling
Zhang, J. J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C. M., & Darnell, J. E., Jr. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15092 · Cited by 485 · see citing works
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · see citing works
Conjunction dysfunction: CBP/p300 in human disease
Giles, R. H., Peters, D. J. M., & Breuning, M. H. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01438-3 · Cited by 400 · see citing works
Janknecht, R., & Hunter, T. (1996) · Nature · doi:10.1038/383022a0 · Cited by 393 · see citing works
Blobel, G. A., Nakajima, T., Eckner, R., Montminy, M., & Orkin, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2061 · Cited by 355 · see citing works
CBP as a transcriptional coactivator of c-Myb.Preprint
Dai, P., Akimaru, H., Tanaka, Y., Hou, D., Yasukawa, T., Kanei‐Ishii, C., Takahashi, T., & Ishii, S. (1996) · Genes & Development · doi:10.1101/gad.10.5.528 · Cited by 344 · see citing works
CBP‐induced stimulation of c‐Fos activity is abrogated by E1A.
Bannister, A. J., & Kouzarides, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00157.x · Cited by 336 · see citing works
Kitabayashi, I., Yokoyama, A., Shimizu, K., & Ohki, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.2994 · Cited by 305 · see citing works
Hagemeier, C., Bannister, A. J., Cook, A., & Kouzarides, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1580 · Cited by 303 · see citing works
Tanaka, Y., Naruse, I., Maekawa, T., Masuya, H., Shiroishi, T., & Ishii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10215 · Cited by 294 · see citing works
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 282 · cited 2× · see citing works
“PU.1 has been reported to interact with retinoblastoma protein (Rb) and TFIID through the N-terminal region (1 ± 75 aa) (Hagemeier et al., 1993), NF-EM5/Pip through the PEST domain (119 ± 160 aa) (Eisenbeis et al., 1995) and NF-IL6b through the Ets domain (245 ± 272 aa) (Nagulapalli et al., 1995).”
BackgroundNeutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B
Chen, H., Zhang, P., Voso, M., Hohaus, S., Gonzalez, D., Glass, C., Zhang, D., & Tenen, D. (1995) · Blood · doi:10.1182/blood.v85.10.2918.bloodjournal85102918 · Cited by 216 · see citing works
Yang, C., Shapiro, L. H., Rivera, M., Kumar, A., & Brindle, P. K. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2218 · Cited by 211 · see citing works
Oelgeschläger, M., Janknecht, R., Krieg, J., Schreek, S., & Lüscher, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00637.x · Cited by 210 · see citing works
Spi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189 · see citing works
Zhang, D., Hohaus, S., Voso, M. T., Chen, H.-M., Smith, L. T., Hetherington, C. J., & Tenen, D. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_14 · Cited by 131 · see citing works
Nagulapalli, S., Pongubala, J. M., & Atchison, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4330 · Cited by 110 · see citing works
Spi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110 · see citing works
Cheng, X., Reginato, M. J., Andrews, N. C., & Lazar, M. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1407 · Cited by 102 · see citing works
Yamada, T., Kondoh, N., Matsumoto, M., Yoshida, M., Maekawa, A., & Oikawa, T. (1997) · Blood · doi:10.1182/blood.v89.4.1383 · Cited by 91 · see citing works
Self-citationGong, Q., McDowell, J. C., & Dean, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6055 · Cited by 90 · see citing works
Rao, G., Rekhtman, N., Cheng, G., Krasikov, T., & Skoultchi, A. I. (1997) · Oncogene · doi:10.1038/sj.onc.1200807 · Cited by 89 · see citing works
The Ets-Related Transcription Factor PU.1 Immortalizes Erythroblasts
Schuetze, S. M., Stenberg, P. E., & Kabat, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5670 · Cited by 87 · see citing works
Essential fatty acids and breast cancer: A case-control study in Uruguay
Stéfani, E. D., Deneo‐Pellegrini, H., Mendilaharsu, M., & Ronco, Á. L. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980518)76:4 · Cited by 75 · see citing works
Self-citationBellón, T., Perrotti, D., & Calabretta, B. (1997) · Blood · doi:10.1182/blood.v90.5.1828 · Cited by 62 · see citing works
Functional interference between the Spi‐1/PU.1 oncoprotein and steroid hormone or vitamin receptors.
Gauthier, J. M., Bourachot, B., Doucas, V., Yaniv, M., & Moreau-Gachelin, F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06203.x · Cited by 58 · see citing works
The Ets-Related Transcription Factor PU.1 Immortalizes Erythroblasts
Schuetze, S. M., Stenberg, P. E., & Kabat, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5670-5678.1993 · Cited by 42 · see citing works
Beug, H., Bauer, A., Dolznig, H., Lindern, M. V., Lobmayer, L., Mellitzer, G., Steinlein, P., Wessely, O., & Müllner, E. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00032-7 · Cited by 30 · see citing works
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 684 · see citing works
Self-citationRoe, J., Mercan, F., Rivera, K. D., Pappin, D., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.011 · Cited by 332 · see citing works
“Interestingly, C/EBPa, C/EBPb, PU.1, and MYB have all been shown previously to interact with p300 or CBP (Dai et al., 1996; Mink et al., 1997; Yamamoto et al., 1999).”
BackgroundCREB-binding protein and p300: molecular integrators of hematopoietic transcription
Blobel, G. A. (2000) · Blood · doi:10.1182/blood.v95.3.745.003k05_745_755 · Cited by 256 · see citing works
1 ,25-dihydroxyvitamin D3 is a potent suppressor of interferon -mediated macrophage activation
Helming, L. (2005) · Blood · doi:10.1182/blood-2005-03-1029 · Cited by 252 · see citing works
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243 · see citing works
ETS transcription factors: Possible targets for cancer therapy
Oikawa, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03320.x · Cited by 191 · see citing works
Self-citationNguyen, V. T., & Benveniste, E. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002482200 · Cited by 151 · see citing works
Functional Cross-Antagonism between Transcription Factors FLI-1 and EKLF
Starck, J., Cohet, N., Gonnet, C., Sarrazin, S., Doubeikovskaia, Z., Doubeikovski, A., Verger, A., Duterque‐Coquillaud, M., & Morlé, F. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1390-1402.2003 · Cited by 144 · see citing works
“On the other hand, it has been shown very recently that the repression activity of the other ETS family protein, SPI-1/PU.1, involves protein-protein interaction with the acetyltransferase domain of CBP and inhibition of the CBP-mediated acetylation of many different nuclear factors, including GATA-1 and EKLF (29).”
BackgroundInfluentialLee, D. K., Park, S. H., Yi, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.856201 · Cited by 140 · see citing works
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., Hara, E., Tenen, D. G., Hozumi, N., & Oikawa, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209272 · Cited by 132 · see citing works
“Immunoprecipitation and immunoblotting were performed as we reported (Yamamoto et al., 1999), with minor modifications.”
BackgroundMethodInfluentialSelf-citationOikawa, T., Yamada, T., Kihara-Negishi, F., Yamamoto, H., Kondoh, N., Hitomi, Y., & Hashimoto, Y. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400534 · Cited by 109 · see citing works
“with the region spanning residues 1283 ± 1915 of the CREB binding protein (CBP), overlapping with the adenovirus E1A-binding site.(13) CBP and the related protein p300 have been reported to interact with a variety of transcription factors, including CREB, AP-1 (Fos/Jun), c-Myb, nuclear hormone receptors (NHRs), STATs,…”
BackgroundSelf-citationKrysinska, H., Hoogenkamp, M., Ingram, R., Wilson, N., Tagoh, H., Laslo, P., Singh, H., & Bonifer, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01915-06 · Cited by 102 · see citing works
“It has been shown previously that the activity of CBP can be regulated as well (35); it was therefore possible that CBP was recruited but was inactive.”
BackgroundInfluentialPU.1 and pRB Interact and Cooperate To Repress GATA-1 and Block Erythroid Differentiation
Rekhtman, N., Choe, K. S., Matushansky, I., Murray, S., Stopka, T., & Skoultchi, A. I. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7460-7474.2003 · Cited by 102 · see citing works
Fernández, L. Á., Winkler, M., & Grosschedl, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.196-208.2001 · Cited by 97 · see citing works
“1 can interact with the HAT CREB-binding protein (81).”
BackgroundIndependent Repressor Domains in ZEB Regulate Muscle and T-Cell Differentiation
Postigo, A., & Dean, D. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.7961 · Cited by 102 · see citing works
NF-IL6 (C/EBPβ) Vigorously Activates il1b Gene Expression via a Spi-1 (PU.1) Protein-Protein Tether
Yang, Z., Wara-aswapati, N., Chen, C., Tsukada, J., & Auron, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000145200 · Cited by 92 · see citing works
Hu, R., Sharma, S. M., Bronisz, A., Srinivasan, R., Sankar, U., & Ostrowski, M. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01839-06 · Cited by 86 · see citing works
“Further, the N-terminal region of MITF (1-218) (MITF with aa 1 to 218), but not the C-terminal basic helix-loop-helixleucine zipper region (aa 219 to 419), formed a complex with GST-Eos (Fig.”
BackgroundTranscriptional Activation by STAT6 Requires the Direct Interaction with NCoA-1
Litterst, C. M., & Pfitzner, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108132200 · Cited by 83 · see citing works
Wang, J.-M., Lai, M.-Z., & Yang-Yen, H.-F. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1896-1909.2003 · Cited by 83 · see citing works
Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., & Oikawa, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207182 · Cited by 82 · see citing works
“In line with this, we have previously demonstrated that PU.1 interacts with CREB binding protein (CBP), which functions as a coactivator of transcription factors (Yamamoto et al., 1999).”
BackgroundMethodInfluentialSelf-citationGupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74 · see citing works
“1 and other transcription factors in the process of haematopoietic cell differentiation [78].”
BackgroundPU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74 · see citing works
“1 has been reported to interact with the histone acetylase CREB binding protein (CBP) (16), implicating PU.”
BackgroundInfluentialKitajima, K., Masuhara, M., Era, T., Enver, T., & Nakano, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf301 · Cited by 77 · see citing works
Cooperation of STAT-1 and IRF-1 in Interferon-γ-induced Transcription of the gp91 Gene
Kumatori, A., Yang, D., Suzuki, S., & Nakamura, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109803200 · Cited by 72 · see citing works
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 71 · see citing works
“1 binds to the CH3 domain of CBP (82) (Fig.”
BackgroundTRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation
Ferri, F., Parcelier, A., Petit, V., Gallouet, A.-S., Lewandowski, D., Dalloz, M., van den Heuvel, A., Kolovos, P., Soler, E., Squadrito, M. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms9900 · Cited by 71 · see citing works
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., Bansal, R., & Broersen, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210497 · Cited by 73 · see citing works
CBP and p300: versatile coregulators with important roles in hematopoietic gene expression
Blobel, G. A. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.545 · Cited by 69 · see citing works
Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7439-7448.2002 · Cited by 69 · see citing works
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67 · see citing works
“…loss of LPS-induced transcriptional activation, suggesting that phosphorylation of serine 148 is required for inducible transcriptional activation by LPS. Phos-MARECKI phorylation of other serine residues (41, 45, 132, and 133) is required at distinct events in myeloid development and maturation.”
InfluentialAutocrine Induction of the Human Pro-IL-1β Gene Promoter by IL-1β in Monocytes
Toda, Y., Tsukada, J., Misago, M., Kominato, Y., Auron, P. E., & Tanaka, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1984 · Cited by 65 · see citing works
Kihara-Negishi, F., Yamamoto, H., Suzuki, M., Yamada, T., Sakurai, T., Tamura, T., & Oikawa, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204756 · Cited by 65 · see citing works
“We have previously reported that PU.1 interacts with the coactivator CBP and the interaction has been implicated in transactivation (Yamamoto et al., 1999).”
BackgroundMethodResultInfluentialSelf-citationXiong, H., Zhu, C. Y., Li, H., Chen, F., Mayer, L., Ozato, K., Unkeless, J. C., & Plevy, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209583200 · Cited by 64 · see citing works
BSAP Can Repress Enhancer Activity by Targeting PU.1 Function
Maitra, S., & Atchison, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1911-1922.2000 · Cited by 72 · see citing works
RUNX1 regulates corepressor interactions of PU.1
Hu, Z., Gu, X., Baraoidan, K., Ibanez, V., Sharma, A., Kadkol, S., Munker, R., Ackerman, S., Nucifora, G., & Saunthararajah, Y. (2011) · Blood · doi:10.1182/blood-2010-10-312512 · Cited by 63 · see citing works
c-Jun Homodimers Can Function as a Context-Specific Coactivator
Grondin, B., Lefrançois, M., Tremblay, M., Saint-denis, M., Haman, A., Waga, K., Bédard, A., Tenen, D., & Hoang, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00936-06 · Cited by 66 · see citing works
“Together with our observations of a more efficient recruitment of RNA Pol II, we propose that maximal assembly of PIC on the IL-1 promoter is achieved by multiple interactions and recruitment of TFIID and RNA Pol II holoenzymes containing Mediator complexes, CBP/p300, and some general transcription factors by the PU.1-”
BackgroundYin Yang 1 enhancescyclooxygenase-2gene expression in macrophages
Joo, M., Wright, J. G., Hu, N. N., Sadikot, R. T., Park, G. Y., Blackwell, T. S., & Christman, J. W. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00474.2006 · Cited by 62 · see citing works
Oh, I., Lau, A., & Eaves, C. J. (2000) · Blood · doi:10.1182/blood.v96.13.4160 · Cited by 63 · see citing works
Suraweera, N., Meijne, E., Moody, J., Carvajal-Carmona, L. G., Yoshida, K., Pollard, P., Fitzgibbon, J., Riches, A., van Laar, T., Huiskamp, R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208422 · Cited by 60 · see citing works
“…of the protein, this domain interacts with various proteins including GATA1 binding protein 1 (GATA1), CCAAT/enhancer binding protein beta (CEBPB), and other myeloid regulators such as c-jun and RUNX1/ AML-1 (Nagulapalli et al., 1995; Petrovick et al., 1998; Yamamoto et al., 1999).”
Backgroundvan der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 56 · see citing works
Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophils
Fischer, J., Walter, C., Tönges, A., Aleth, H., Jordão, M. J. C., Leddin, M., Gröning, V., Erdmann, T., Lenz, G., Roth, J., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0343-z · Cited by 56 · see citing works
Transcriptional Regulation of the Cyclooxygenase-2 Gene in Macrophages by PU.1
Joo, M., Park, G. Y., Wright, J. G., Blackwell, T. S., Atchison, M. L., & Christman, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306267200 · Cited by 55 · see citing works
Carl, V. S., Brown-Steinke, K., Nicklin, M. J. H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111847200 · Cited by 51 · see citing works
Wittwer, J., Marti-Jaun, J., & Hersberger, M. (2005) · Human Mutation · doi:10.1002/humu.20273 · Cited by 50 · see citing works
“…protein [Hagemeier et al., 1993], the basal transcription factor TBP [Hagemeier et al., 1993], the transcriptional coactivators CBP/p300 [Yamamoto et al., 1999], the transcription factors GATA-1 and GATA-2 [Nerlov et al., 2000; Zhang et al., 1999], and the transcription factor NFEM5/Pip…”
BackgroundEpigenetic control of hematopoiesis: the PU.1 chromatin connection
van Riel, B., & Rosenbauer, F. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0195 · Cited by 47 · see citing works
Lutz, P. G., Houzel-Charavel, A., Moog‐Lutz, C., & Cayre, Y. E. (2001) · Blood · doi:10.1182/blood.v97.8.2449 · Cited by 49 · see citing works
Transcriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 46 · see citing works
Hamdorf, M., Berger, A., Schüle, S., Reinhardt, J., & Flory, E. (2011) · Stem Cells · doi:10.1002/stem.564 · Cited by 45 · see citing works
Curik, N., Burda, P., Vargová, K., Pospíšil, V., Beličková, M., Vlckova, P., Savvulidi, F. G., Nečas, E., Hajkova, H., Haškovec, C., et al. (2012) · Leukemia · doi:10.1038/leu.2012.47 · Cited by 45 · see citing works
Yoshida, H., Ichikawa, H., Tagata, Y., Katsumoto, T., Ohnishi, K., Akao, Y., Naoe, T., Pandolfi, P. P., & Kitabayashi, I. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02422-06 · Cited by 45 · see citing works
“1 and p300/CBP can directly interact, at least in vitro (33); however, we found that their association is rather weak compared with those of other transcription factors such as AML1b.”
BackgroundGeng, C.-D., & Vedeckis, W. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508245200 · Cited by 43 · see citing works
PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
Yashiro, T., Kubo, M., Ogawa, H., Okumura, K., & Nishiyama, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137699 · Cited by 41 · see citing works
“1 is involved in chromatin remodeling by interaction with p300/CBP [12].”
BackgroundShigeno, K., Yoshida, H., Pan, L., Luo, J. M., Fujisawa, S., Naito, K., Nakamura, S., Shinjo, K., Takeshita, A., Ohno, R., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00442-7 · Cited by 42 · see citing works
Nakazawa, Y., Suzuki, M., Manabe, N., Yamada, T., Kihara‐Negishi, F., Sakurai, T., Tenen, D. G., Iwama, A., Mochizuki, M., & Oikawa, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210140 · Cited by 39 · see citing works
“Cell extracts for Luc assays were prepared as described previously (Yamamoto et al., 1999).”
MethodInfluentialSelf-citationCalomme, C., Dekoninck, A., Nizet, S., Adam, E., Nguyên, T. L.-A., den Broeke, A. V., Willems, L., Kettmann, R., Burny, A., & Lint, C. M. V. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13848-13864.2004 · Cited by 39 · see citing works
“1/Spi-B (91, 92), USF2 (12), glucocorticoid receptor (38, 44), IRF1 (71), and IRF2 (56), have been shown to interact with acetyltransferases and/or to be acetylated.”
BackgroundThe Essential Transcriptional Function of BRD4 in Acute Myeloid LeukemiaPreprint
Roe, J., & Vakoc, C. R. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.031039 · Cited by 39 · see citing works
Protein Acetylation Regulates Both PU.1 Transactivation and Igκ 3′ Enhancer Activity
Bai, Y., Srinivasan, L., Perkins, L., & Atchison, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5160 · Cited by 38 · see citing works
Baert, J., Beaudoin, C., Coutte, L., & de Launoit, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107139200 · Cited by 37 · see citing works
Yamada, T., Abe, M., Higashi, T., Yamamoto, H., Kihara‐Negishi, F., Sakurai, T., Shirai, T., & Oikawa, T. (2001) · Blood · doi:10.1182/blood.v97.8.2300 · Cited by 38 · see citing works
Self-citationHa, S.-D., Cho, W., DeKoter, R. P., & Kim, S. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010149 · Cited by 35 · see citing works
Epigenetic Regulation during B Cell Differentiation Controls CIITA Promoter Accessibility
Green, M. R., Yoon, H., & Boss, J. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3865 · Cited by 37 · see citing works
Dekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 34 · see citing works
“Moreover, PU.1 has been shown to interact with chromatin-modifying enzymes: the histone acetyltransferase CREB binding protein (CBP) (Yamamoto et al., 1999) (which also interacts with Spi-B, Yamamoto et al., 2002) and the histone deacetylase HDAC1 (Kihara-Negishi et al., 2001), further implicating PU.1 in chromatin re…”
BackgroundFuglerud, B. M., Ledsaak, M., Rogne, M., Eskeland, R., & Gabrielsen, O. S. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0208-y · Cited by 34 · see citing works
Sugiyama, D., Tanaka, M., Kitajima, K., Zheng, J., Yen, H., Murotani, T., Yamatodani, A., & Nakano, T. (2007) · Blood · doi:10.1182/blood-2007-08-104489 · Cited by 32 · see citing works
Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
Guillouf, C., Gallais, I., & Moreau-Gachelin, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512049200 · Cited by 30 · see citing works
Wei, P. Y., Taniguchi, S., Sakai, Y., Imamura, M., Inoguchi, T., Nawata, H., Oda, S., Nakabeppu, Y., Nishimura, J., & Ikuyama, S. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi136 · Cited by 28 · see citing works
Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207578 · Cited by 26 · see citing works
“Some of these proteins are ubiquitous factors such as the basal transcription factor TFIID (Hagemeier et al., 1993) and the co-activator/integrator CBP (Yamamoto et al., 1999).”
BackgroundTranscriptional Regulation of the p67 Gene
Li, S.-L., Valente, A. J., Wang, L., Gamez, M. J., & Clark, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106111200 · Cited by 27 · see citing works
Modeling the Hematopoietic Landscape
Brown, G., & Ceredig, R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00104 · Cited by 25 · see citing works
“1 binds the histone acetyltransferases CREB-binding protein and p300 (Yamamoto et al., 1999; Bai et al., 2005) and a histone deacetylase complex consisting of histone deacetylase 1 and mammalian Sin3a (Kihara-Negishi et al.”
BackgroundAP-1 is essential for p67phoxpromoter activity
Gauss, K. A., Bunger, P. L., & Quinn, M. T. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.163 · Cited by 25 · see citing works
Structural mechanism of synergistic targeting of the CX3CR1 nucleosome by PU.1 and C/EBPα
Lian, T., Guan, R., Zhou, B., & Bai, Y. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01189-z · Cited by 26 · see citing works
“The N-terminal regions of both PU.1 and C/EBPα interact with basal transcription factors such as TFIID, TFIIB and TBP 28,29 , histone acetyltransferases CREB-binding protein (CBP) 30,31 , as well as SWI/SNF chromatin remodelers 29,32 .”
Yamamoto, H., Kihara‐Negishi, F., Yamada, T., Suzuki, M., Nakano, T., & Oikawa, T. (2002) · PubMed · Cited by 24 · see citing works
Self-citationBisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL-60 cells
Watanabe, H., Adachi, R., Kusui, K., Hirayama, A., Kasahara, T., & Suzuki, K. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00182-6 · Cited by 23 · see citing works
Kwan, M., Powell, D. R., Nachman, T. Y., & Brown, M. A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425619 · Cited by 22 · see citing works
Listman, J. A., Wara-aswapati, N., Race, J. E., Blystone, L. W., Walker‐Kopp, N., Yang, Z., & Auron, P. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509143200 · Cited by 21 · see citing works
PU.1 Regulates Positive Regulatory Domain I-Binding Factor 1/Blimp-1 Transcription in Lymphoma Cells
Desai, S., Bolick, S. C. E., Maurin, M. M., & Wright, K. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901120 · Cited by 21 · see citing works
Context-dependent Pax-5 repression of a PU.1/NF-κB regulated reporter gene in B lineage cells
Linderson, Y., French, N. S., Neurath, M. F., & Pettersson, S. (2001) · Gene · doi:10.1016/s0378-1119(00)00546-1 · Cited by 19 · see citing works
Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1
Hirose, S., Nishizumi, H., & Sakano, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.212 · Cited by 18 · see citing works
Molecular basis of Stat1 and PU.1 cooperation in cytokine-induced Fc receptor I promoter activation
Aittomäki, S. (2004) · International Immunology · doi:10.1093/intimm/dxh037 · Cited by 18 · see citing works
Nguyên, T. L.-A., Calomme, C., Wijmeersch, G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404081200 · Cited by 16 · see citing works
Luo, L., Chen, W., Yin, J. Q., & Xu, R. (2017) · Scientific Reports · doi:10.1038/srep40463 · Cited by 16 · see citing works
SPI-C and STAT6 can cooperate to stimulate IgE germline transcription
Carlsson, R., Thorell, K., Liberg, D., & Leanderson, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.026 · Cited by 15 · see citing works
Koli, S., Mukherjee, A., & Reddy, K. V. R. (2015) · Reproduction Fertility and Development · doi:10.1071/rd15145 · Cited by 14 · see citing works
Roullet, M. R., & Bagg, A. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.6.805 · Cited by 14 · see citing works
Kihara-Negishi, F., Suzuki, M., Yamada, T., Sakurai, T., & Oikawa, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.098 · Cited by 13 · see citing works
Self-citationYamada, T., Suzuki, M., Satoh, H., Kihara‐Negishi, F., Nakano, H., & Oikawa, T. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.023 · Cited by 13 · see citing works
Self-citationAittomäki, S., Yang, J., Scott, E. W., Simon, M. C., & Silvennoinen, O. (2002) · Blood · doi:10.1182/blood-2001-12-0236 · Cited by 13 · see citing works
Yamada, T., Shimizu, T., Suzuki, M., Kihara‐Negishi, F., Nanashima, N., Sakurai, T., Yang, F., Akita, M., Oikawa, T., & Tsuchida, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.11.005 · Cited by 11 · see citing works
Self-citationPlant, E., Bellefroid, M., & Lint, C. M. V. (2023) · Retrovirology · doi:10.1186/s12977-023-00623-w · Cited by 11 · see citing works
“1 [148, 149], or the weakly bound CREB/ATF factors, reinforcing the open chromatin state by acetylating the H3 and H4 histone tails.”
BackgroundZhang, K., Lv, D., & Li, R. (2019) · Virology · doi:10.1016/j.virol.2019.11.011 · Cited by 9 · see citing works
“1 also interacts with CRE-binding protein (CBP) or p300 and functions as a coactivator for several other transcription factors (Yamamoto et al., 1999).”
BackgroundOh, I., Lau, A., & Eaves, C. J. (2000) · Blood · doi:10.1182/blood.v96.13.4160.h8004160_4160_4168 · Cited by 9 · see citing works
Genetic determination of the role of PU.1 in macrophage gene expression
Joo, M., Kwon, M., Azim, A. C., Sadikot, R. T., Blackwell, T. S., & Christman, J. W. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.189 · Cited by 8 · see citing works
Shen, X., Li, X., Wu, T., Guo, T., Lv, J., He, Z., Luo, M., Zhu, X., Tian, Y., Lai, W., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01179-1 · Cited by 8 · see citing works
“PU.1 activates transcription by recruiting CREB-binding protein (CBP) to bridge the basal transcription machinery and promote regional H3K27ac intensity [74, 75].”
BackgroundLemieux, M. E., Cheng, Z., Zhou, Q., White, R., Cornell, J. E., Kung, A. L., & Rebel, V. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024153 · Cited by 7 · see citing works
Carter, M. J., Bogdanov, Y. D., Smith, R. C. G., Cox, K. L., Frampton, S., Ferson, L., Foxall, R. B., Hussain, K., Strefford, J. C., Beers, S. A., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf109 · Cited by 6 · see citing works
Ishii, H., Sen, R., & Pazin, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308973200 · Cited by 6 · see citing works
Park, J., Jung, S.-H., Seo, H., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.005 · Cited by 3 · see citing works
PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
Takahashi, S. (2011) · InTech eBooks · doi:10.5772/25853 · Cited by 2 · see citing works
“…of PU.1 with the transcriptional coactivator CBP, which www.intechopen.com (Inomata et al., 2006), Flt3 may be classified into the upper group, although direct binding of PU.1 to the Flt3 gene promoter has not been examined. enhances the transcriptional activity of PU.1 (Yamamoto et al., 1999).”
BackgroundInfluentialBatista, C. R., & DeKoter, R. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101960 · Cited by 2 · see citing works
Structural mechanism of synergistic targeting of the CX3CR1 nucleosome by PU.1 and C/EBP⍺Preprint
Lian, T., Guan, R., Zhou, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.25.554718 · Cited by 2 · see citing works
- Authors
- Yamamoto, H., Kihara-Negishi, F., Yamada, T., Hashimoto, Y., & Oikawa, T.
- Affiliations
- Sasaki Institute (JP)
- ORCID
- Yamada, Toshiyuki
- Venue
- Oncogene
- Published
- 1999-02-18
- Volume
- 18
- Issue
- 7
- Pages
- 1495-1501
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2318149005
- Semantic Scholar
- b28b07fc5cb5ab0b001e5a4822b86f270638d7f1
- Cited by
- 111
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 1 · 2019: 5 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- PU.1, CREB-binding protein, CBP, transcriptional coactivator, ETS transcription factors, protein-protein interaction, transactivation domain, transcriptional activation
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review